![PDF) Efficacy, safety and tolerability of two risperidone dosing regimens in adolescent schizophrenia: Double-blind study PDF) Efficacy, safety and tolerability of two risperidone dosing regimens in adolescent schizophrenia: Double-blind study](https://i1.rgstatic.net/publication/23964058_Efficacy_safety_and_tolerability_of_two_risperidone_dosing_regimens_in_adolescent_schizophrenia_Double-blind_study/links/5b6da488a6fdcc87df710fc3/largepreview.png)
PDF) Efficacy, safety and tolerability of two risperidone dosing regimens in adolescent schizophrenia: Double-blind study
![PDF) Efficacy of risperidone in children with disruptive behavioural disorders | Michael Duhig - Academia.edu PDF) Efficacy of risperidone in children with disruptive behavioural disorders | Michael Duhig - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42124146/mini_magick20190218-3473-1h3tcss.png?1550488273)
PDF) Efficacy of risperidone in children with disruptive behavioural disorders | Michael Duhig - Academia.edu
![Risperidone in the management of agitation and aggression associated with psychiatric disorders | European Psychiatry | Cambridge Core Risperidone in the management of agitation and aggression associated with psychiatric disorders | European Psychiatry | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20200306082325241-0978:S0924933800239758:S0924933800239758_tab3.png?pub-status=live)
Risperidone in the management of agitation and aggression associated with psychiatric disorders | European Psychiatry | Cambridge Core
![Pharmaceuticals | Free Full-Text | Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics | HTML Pharmaceuticals | Free Full-Text | Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00108/article_deploy/html/images/pharmaceuticals-15-00108-g004.png)
Pharmaceuticals | Free Full-Text | Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics | HTML
![Pipamperone Population Pharmacokinetics Related to Effectiveness and Side Effects in Children and Adolescents | SpringerLink Pipamperone Population Pharmacokinetics Related to Effectiveness and Side Effects in Children and Adolescents | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-020-00894-y/MediaObjects/40262_2020_894_Fig4_HTML.png)
Pipamperone Population Pharmacokinetics Related to Effectiveness and Side Effects in Children and Adolescents | SpringerLink
![A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia | Journal of Child and Adolescent Psychopharmacology A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia | Journal of Child and Adolescent Psychopharmacology](https://www.liebertpub.com/cms/10.1089/cap.2008.0144/asset/images/medium/fig-1.gif)
A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia | Journal of Child and Adolescent Psychopharmacology
![Autismespectrumstoornissen (ASS) bij kinderen en adolescenten – Kenniscentrum Kinder- en Jeugdpsychiatrie Autismespectrumstoornissen (ASS) bij kinderen en adolescenten – Kenniscentrum Kinder- en Jeugdpsychiatrie](https://i.ytimg.com/vi/duFHi6T4ROg/maxresdefault.jpg)